Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B

PHASE3SuspendedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2009

Conditions
Influenza
Interventions
DEVICE

fluID Rapid Influenza Test

The fluID™ Rapid Influenza Test is an in vitro diagnostic assay designed to be used with a reader for the qualitative detection of influenza type A and type B nucleoprotein antigens, and the differentiation of influenza type A subtypes A/H1 and A/H3 antigens associated with the seasonal influenza H1N1 and H3N2, in nasal swabs, nasopharyngeal swabs and nasal wash/aspirate specimens. The test is intended as an aid in the rapid, qualitative diagnosis of influenza type A and type B viral infections in patients symptomatic with influenza-like illness. The fluID™ Rapid Influenza Test is intended for use by a healthcare professional in a laboratory or Point-of-Care (POC) setting.

DEVICE

BinaxNOW® Influenza A & B

The BinaxNOW Influenza A \& B Test is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab and nasal wash/aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. Negative test results should be confirmed by culture.

Trial Locations (2)

53226

Medical College of Wisconsin, Milwaukee

71103

Louisiana State University Health Sciences Center, Shreveport

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nanogen, Inc.

INDUSTRY

NCT00828100 - Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B | Biotech Hunter | Biotech Hunter